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Luciana Luchelli1,2,3, Marı´a Gabriela Thomas1,2 and Graciela L. Boccaccio1,2,3,*
ABSTRACT
Repression of mRNA translation is linked to the formation of specific
cytosolic foci such as stress granules and processing bodies, which
store or degrade mRNAs. In neurons, synaptic activity regulates
translation at the post-synapse and this is important for plasticity. N-
methyl-D-aspartate (NMDA) receptor stimulation downregulates
translation, and we speculate that this is linked to the formation of
unknown mRNA-silencing foci. Here, we show that the 59-39
exoribonuclease XRN1 forms discrete clusters associated with the
post-synapse that are different from processing bodies or stress
granules, and we named them synaptic XRN1 bodies (SX-bodies).
Using primary neurons, we found that the SX-bodies respond to
synapse stimulation and that their formation correlates inversely
with the local translation rate. SX-bodies increase in size and
number upon NMDA stimulation, and metabotropic glutamate
receptor activation provokes SX-body dissolution, along with
increased translation. The response is specific and the previously
described Smaug1 foci and FMRP granules show a different
response. Finally, XRN1 knockdown impairs the translational
repression triggered by NMDA. Collectively, these observations
support a role for the SX-bodies in the reversible masking and
silencing of mRNAs at the synapse.
KEY WORDS: P body, RNA granule, Stress granule, XRN1,
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INTRODUCTION
Regulation of protein synthesis at the post-synapse contributes to
synaptic plasticity. Different stimuli elicit mRNA-specific effects as
well as global changes in translation. It was shown both in cultured
neurons and isolated synaptoneurosomes that the activation of
metabotropic glutamate receptors (mGluR) enhances global protein
synthesis by multiple pathways. A different response follows N-
methyl-D-aspartic acid receptor (NMDAR) stimulation, which
globally attenuates protein synthesis at the synapse. Dendritic
translation in cultured neurons expressing a GFP-based reporter is
stimulated by exposure to dihydroxyphenylglycine (DHPG) – an
agonist of mGluR – or NMDAR blockers, and incorporation of
radioactive amino acids is reduced in neurons exposed to short
pulses of NMDA (Marin et al., 1997; Job and Eberwine, 2001; Sutton
et al., 2004). In addition, prolonged exposure of synaptoneurosomes
to glutamate reduces amino acid incorporation; a 30-s exposure to
glutamate plus NMDA provokes an acute reduction followed by an
enhancement of protein synthesis at 15 minutes after the pulse. By
contrast, continuous exposure to DHPG increases the incorporation
of amino acids immediately after a pulse (Leski and Steward, 1996;
Scheetz et al., 2000; Weiler et al., 2004). NMDAR stimulation
affects translation through multiple mechanisms. It activates the
mammalian/mechanistic target of rapamycin (mTOR), which in
turn stimulates a number of translation factors and affects several
miRNA targets in opposite directions (Weiler and Greenough,
1993; Banko et al., 2006; Sosanya et al., 2013). The integration of
all these pathways results in the de-repression of a number of
transcripts and the repression of others, and it was suggested that
the reduction in the global protein synthesis rate induced by
NMDA facilitates the translation of specific messengers, including
that of Ca2+/CaM-dependent protein kinase II (CaMKII) and
activity-regulated cytoskeletal-associated protein (Arc, also known
as Arg3.1) mRNAs, which appear to compete poorly with other
transcripts (Marin et al., 1997; Scheetz et al., 2000; Sutton et al.,
2004; Sutton et al., 2006; Sutton et al., 2007; Park et al., 2008).
In most cell types, translation inhibition is linked to the
formation of supramolecular aggregates containing silenced
messengers and associated repressors, which we have termed
mRNA-silencing foci (Buchan and Parker, 2009; Thomas et al.,
2011). Processing bodies are ubiquitous foci that contain several
molecules involved in mRNA repression and decay. Historically,
the mammalian 59-39 exoribonuclease 1 (XRN1) was the first
RNA decay molecule detected in cytoplasmic foci (Bashkirov
et al., 1997). Thereafter, the decapping factors DCP1 and DCP2
and additional decapping co-activators were reported to be present
in the XRN1 foci (Ingelfinger et al., 2002). XRN1 is a conserved
molecule that mediates the 59-39 degradation of 59 monophosphate
transcripts. XRN1 substrates are mostly decapped mRNAs and 39
fragments produced by endonucleolytic cleavage during nonsense-
mediated decay (NMD) or RNA-induced silencing complex
(RISC)-mediated silencing (Lejeune et al., 2003; Gatfield and
Izaurralde, 2004; Souret et al., 2004; Bagga et al., 2005; Jones
et al., 2012; Nagarajan et al., 2013; Siwaszek et al., 2014).
Remarkably, both in animals and plants, XRN1 deletion affects
specific subsets of transcripts, suggesting that bulk mRNA decay is
not the major activity of this enzyme (Souret et al., 2004;
Rymarquis et al., 2011). Substrate specificity would be achieved
through the preferential binding of XRN1, which might involve
RNA binding proteins (RBPs) that could influence the recruitment
of XRN1 to selected targets. For example, specific hexamer
sequences at the 59 end either stimulate or inhibit degradation
by the plant homolog XRN4 through unknown mechanisms
(Rymarquis et al., 2011). Moreover, recombinant mammalian
XRN1 preferentially binds and degrades RNAs carrying G-
quartets, which are important motifs for the binding of fragile X
1Fundacio´n Instituto Leloir, C1405BWE Buenos Aires, Argentina. 2Instituto de
Investigaciones Bioquı´micas Buenos Aires-Consejo Nacional de Investigaciones
Cientı´ficas y Tecnolo´gicas, C1405BWE Buenos Aires, Argentina. 3Facultad de
Ciencias Exactas y Naturales, University of Buenos Aires, C1428EHA Buenos
Aires, Argentina.
*Author for correspondence (gboccaccio@leloir.org.ar)
Received 12 September 2014; Accepted 13 February 2015
 2015. Published by The Company of Biologists Ltd | Journal of Cell Science (2015) 128, 1542–1554 doi:10.1242/jcs.163295
1542
Jo
u
rn
a
l
o
f
C
e
ll
S
ci
e
n
ce
mental retardation protein (FMRP) to dendritic transcripts
(Bashkirov et al., 1997; Darnell et al., 2001). In addition, the
expression of the Drosophila XRN1 homolog, termed Pacman, is
controlled spatially and temporally, suggesting a regulatory role.
Invertebrate XRN1 affects embryo development and fly pacman
and Caenorhabditis elegans XRN1 control epithelial closure,
wound healing and related morphological processes. Lower
eukaryote XRN1 influences cell proliferation, and mutations in
plant XNR4 affect the stress response and generate developmental
abnormalities (Newbury and Woollard, 2004; Jones et al., 2013;
Nagarajan et al., 2013). The biological relevance of vertebrate
XRN1 is poorly described and, here, we show that rodent XRN1
responds to synaptic activity and regulates protein synthesis in
hippocampal neurons.
NMDAR stimulation triggers translational silencing at the
post-synapse, and we hypothesized that a specific type of
processing body or related mRNA-silencing foci is concomitantly
induced (Pascual et al., 2012). Different types of processing bodies
containing subsets of components were reported in dendrites
and synapse surroundings (Cougot et al., 2008; Zeitelhofer et al.,
2008; di Penta et al., 2009; Miller et al., 2009; Pradhan et al.,
2012). Here, we show that XRN1 forms clusters associated with
the post-synapse that we termed synaptic XRN1 bodies (SX-
bodies), as they do not contain the canonical processing
body components DCP1A, Ge-1 (also known as Hedls, RCD8 or
EDC4) or Rck (also known as p54 or DDX6) and are also different
from the previously described Smaug1 (also known as Samd4a)
foci (S-foci) and FMRP or survival of motor neuron (SMN1)
granules. The XRN-1-positive bodies are also different from stress
granules, which are specifically formed during the stress response.
We found that the presence of XRN-1-positive puncta at
the synapses of cultured hippocampal neurons is affected by
synaptic stimulation and inversely correlates with the local protein
synthesis rate. NMDAR stimulation enhanced SX-body formation
and inhibited translation at spines and dendrites, whereas mGluR
activation provoked the dissolution of the SX-bodies and
stimulated local translation. We compared the behavior of the
SX-bodies to that of S-foci and FMRP-positive granules, also
involved in translational regulation at the synapse (Antar et al.,
2004; Baez et al., 2011; Darnell et al., 2011; Graber et al., 2013).
Similar to the SX-bodies, the S-foci and the FMRP-positive
granules transiently dissolved upon DHPG, although with
different kinetics. In striking contrast to the enhanced formation
of the SX-bodies upon NMDAR stimulation, the S-foci dissolved
and the FMRP-positive granules did not respond to NMDA,
as reported previously (Antar et al., 2004; Baez et al., 2011).
The size and number of XRN-1-positive bodies were affected
by drugs that stabilize polysomes, suggesting that transcripts
released from polysomes upon NMDAR stimulation are directed
to the XRN1 bodies. Finally, the small interfering (si)RNA-
mediated knockdown of XRN1 impaired the decrease in
translation induced by NMDA. Collectively, these observations
suggest that the SX-bodies contribute to the inhibition of protein
synthesis upon exposure to NMDA by sequestering and/or
degrading mRNAs.
RESULTS
We are interested in mRNA-silencing bodies putatively involved
in the translational silencing that occurs at the post-synapse
upon NMDAR stimulation. First, we defined the population of
processing-body-related foci present at the post-synapses and
focused on XRN1 particles. Then, we investigated whether the
local changes in translational activity induced by synaptic
stimulation correlate with their assembly or disassembly.
Finally, we performed functional studies that suggest that the
XRN-1-positive bodies are involved in translational silencing at
the post-synapse.
XRN1 forms synaptic bodies that are different from
processing bodies
We analyzed the subcellular distribution of selected processing
body components in hippocampal neurons at 17 days in vitro. At
this time in culture, neurons show mature dendritic spines and
respond to specific paradigms of synaptic stimulation (Baez et al.,
2011). We focused on XRN1, DCP1a, Ge-1/Hedls/RCD8/EDC4
(which is a decapping co-activator required for processing body
integrity) and Rck/p54/DDX6 (a translational repressor and co-
activator of decapping that is also required for processing body
assembly). All of these processing body components formed
puncta located in the cell soma and dendrites (Fig. 1A–G and
data not shown), as described previously by us and others
(Cougot et al., 2008; Zeitelhofer et al., 2008; Miller et al., 2009;
Thomas et al., 2011). For all these molecules, the number of foci
along dendrites was comparable. However, their presence at the
synapses – identified by staining of the pre-synaptic molecule
synapsin – was different. We considered a given body to be
associated with a synapse when the synapsin cluster overlapped
by .25% of its area. We found that whereas ,60% of the XRN1
bodies associated with the synapses (Fig. 1A), most DCP1a or
Ge-1/Hedls/RCD8/EDC4 puncta localized at the dendritic shaft,
and only 23% and 20% of them were found close to the synapsin
clusters (Fig. 1B). Reciprocally, 40–70% of the synapses in
hippocampal neurons contain XRN1 bodies in the surroundings;
whereas the proportion of synapses with DCP1a or Ge-1/Hedls/
RCD8/EDC4 was significantly lower (Fig. 1B,C). The presence
of XRN1 was analyzed with two polyclonal antibodies (see
Materials and Methods) and both antibodies detected a similar
number of synaptic XRN1 clusters, no larger than 0.3–0.6 mm
in diameter. Random colocalization of XRN1 granules with
synapsin clusters was assessed as described in Materials and
Methods. Briefly, we generated randomized images by strategies
described previously (reviewed in Dunn et al., 2011) and found
that the colocalization between XRN1 and synapsin was up to ten
times higher than the random values, with highly significant P-
values (Fig. 1D). Similarly, although much lower, the presence of
DCP1a at the synapse was above the expected random
colocalization and was statistically significant (Fig. 1D).
In addition, we found that, in dendrites, the XRN1 puncta
showed a very low level of colocalization with DCP1a. Between
5 and 10% of the XRN1 particles contained DCP1a and only 6–
10% of DCP1a-containing dendritic bodies contained XRN1
(Fig. 1E). Random colocalization for this pair was calculated as
above and we found that it was lower than the experimental
values (Fig. 1F). By contrast, half of the dendritic DCP1a bodies
contained Ge-1/Hedls/RCD8/EDC4 and, conversely, 43% of
Ge-1/Hedls/RCD8/EDC4 bodies contained DCP1a. The random
colocalization for these pairs was much lower (Fig. 1G). The
colocalization between XRN1 and DCP1a was much higher in the
soma, where the puncta positive for these molecules colocalized
almost completely, as reported previously (Cougot et al., 2008).
For comparison, the colocalization between XRN1 and DCP1a
was analyzed in U2OS cells. As expected, 93% of XRN1 bodies
contained DCP1a and, conversely, 96% of the DCP1a bodies
contained XRN1, Ge-1/Hedls/RCD8/EDC4 and Rck/p54/DDX6.
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A population of small XRN1 foci lacking DCP1a was also present
in U2OS cells (not depicted). The analysis of Ge-1/Hedls/RCD8/
EDC4 and Rck/p54/DDX6 in the XRN1 bodies was not feasible
as the primary antibodies against all these molecules were raised
in rabbit. However, we speculate that these processing body
components are scarcely present in the synaptic XRN1-positive
puncta, as judged from the relatively lower abundance of Ge-1/
Hedls/RCD8/EDC4 and Rck/p54/DDX6 in the vicinity of the
synapse (Fig. 1C; data not shown). Thus, the XRN1 clusters
located at the synapse are not canonical processing bodies, and
we termed them synaptic XRN1-bodies (SX-bodies). Next, we
investigated whether the XRN1-positive puncta contain FMRP,
SMN or Smaug1/Samd4a, three important RBPs that are involved
in RNA transport and localized translation, and we found that
these markers did not significantly colocalize with XRN1. Only
662% (mean6s.d.) of the SX-bodies contained FMRP; 563%
contained transfected hSmaug1-V5 and virtually none of them
contained SMN (Fig. 1E).
The presence of XRN1 at the synapse was further analyzed in
mouse hippocampal slices. We focused on the cornu ammonis
(CA) region, specifically the CA1 and CA3 regions, which offer
the possibility to visualize an ordered array of dendrites and
synapses, respectively. Paralleling the distribution of XRN1 in
cultured hippocampal neurons, XRN1 formed clusters of 0.3–
Fig. 1. XRN1 forms synaptic foci that are
different from processing bodies.
Hippocampal neurons were stained for tubulin
bIII (TubbIII), the pre-synaptic component
synapsin I (Syn) and XRN1 or the indicated
molecules. (A) A representative magnification
of a distal dendrite is depicted in the bottom
panel. XRN1 foci are present at the synapses
and in the dendritic shaft. (B) Foci of DCP1a or
Ge-1/Hedls/RCD8/EDC4 in representative
dendritic fragments. (C) Localization of the foci
of XRN1, DCP1a or Ge-1/Hedls/RCD8/EDC4
relative to synapsin clusters. A synapse was
considered to contain a given focus when the
synapsin cluster overlapped more than 25% of
the focus area. Examples of XRN1 foci
overlapping or contacting synapsin clusters, or
with no contact are depicted. In each case,
1000 synapses from 40 neurons on duplicate
coverslips were analyzed. (D) Randomized
images of representative dendritic fragments
of ,15 mm in length stained for synapsin,
XRN1 and DCP1a were generated as
described in Materials and Methods. A
minimum of seven randomized images was
used in each case. The number of double- or
single-stained pixels was analyzed by using
ImageJ for each pair of molecules. The
colocalization observed in each original
micrograph (Exp) and the mean colocalization
in the randomized images (Ran) is indicated
as the fraction of double-stained pixels relative
to single-stained pixels. (E) DCP1a, FMRP,
SMN and transfected Smaug1/Samd4a
tagged with V5 do not colocalize with XRN1.
Representative dendritic fragments are
depicted. Two independent transfection
experiments yielded similar results.
(F,G) Random colocalization between XRN1
and Dcp1a and between Dcp1a and Hedls
was analyzed as in D. Scale bars: 10 mm (A,
top), 2 mm (A, bottom), 1 mm (B,E). Data in D,F
and G show the mean6s.d.; *P#0.05;
**P#0.001; ***P#0.0001; ns, not significant.
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0.6 mm in diameter in CA1 dendrites. In addition, we found that
,60% of the synapses in the adult CA3 area contained XRN1-
positive puncta (Fig. 2A,B). To confirm that XRN1 is associated
with the post-synaptic side of the synapse, we fractionated
hippocampal synaptoneurosomes (Sn) as described previously
(Baez et al., 2011). We found that XRN1 co-purified with the
post-synaptic density protein 95 (PSD95, also known as DLG4).
Both molecules remained associated with the fraction enriched in
post-synaptic components (PSD) and were excluded from the
soluble fraction (Sol) enriched in the pre-synaptic marker
synapsin (Fig. 2C). Collectively, these observations indicate
that a large proportion of hippocampal dendritic spines contain
XRN1 bodies that exclude decapping molecules, as well as
FMRP, Smaug1/Samd4a and SMN, which would be involved in
different regulatory pathways.
The SX-bodies behave like mRNA-silencing foci
We speculated that, like the processing bodies in most cell types,
the XRN1-positive bodies contain repressed messengers that can
resume translation. In this case, their presence should correlate
inversely with polysome stabilization and should be affected by
RNA breakdown, as is the case for processing bodies (Thomas
et al., 2012). We investigated the response of the XRN1-bodies to
cycloheximide, a polysome-stabilizing drug, and to puromycin,
which provokes polysome disassembly. After a 10-minute exposure
to cycloheximide, we found that both the size and the number of the
XRN1-positive puncta decreased significantly, and they moderately
increased upon a 10-minute treatment with puromycin. Both
synaptic and extra-synaptic XRN1 bodies were similarly affected
(Fig. 3A). Next, we treated live-permeabilized neurons with RNase
as described previously (Thomas et al., 2012). We found that RNA
digestion provoked a substantial loss of synaptic XRN1 puncta
without affecting the synapsin patches (Fig. 3B). Collectively, these
observations are compatible with the speculation that SX-bodies
contain RNA and that they exchange transcripts directly with the
polysomes or with some other cytosolic compartment in
equilibrium with polysomes. In addition, this suggests that SX-
body assembly involves pre-existing XRN1 molecules and that de
novo protein synthesis is not required.
Fig. 2. Presence of XRN1 foci at the postsynapse. (A,B) XRN1, tubulin
bIII (TubbIII) and the pre-synaptic component synapsin I (Syn) were stained
in adult hippocampus slices, or rabbit preimmune serum (PI) was used. (A) A
magnification of the CA1 region, including cell bodies and dendrites, is
depicted. XRN1 puncta are detected along dendrites. (B) Magnification of the
CA3 region showing the presence of several XRN1 foci associated with the
synapses. Scale bars: 10 mm (A), 2 mm (B, left), 1 mm (B, right).
(C) Synaptoneurosomes (Sn) isolated from adult hippocampus (Hipp) were
separated into a soluble fraction (Sol) enriched in presynaptic components
and that does not include PSD95, and a postsynaptic-density-enriched
fraction (PSD). XRN1 co-purified with PSD95 in the PSD fractions, and both
molecules are absent from the pre-synaptic fraction. A representative
western blot out of three independent fractionations is depicted.
Fig. 3. SX-bodies are affected by translational inhibitors. (A) Neurons
were exposed to cycloheximide (CHX) or puromycin (PUR) for 10 minutes,
and the size and number of the SX-bodies were analyzed in 200 synapses
from ten neurons for each treatment from duplicate coverslips. Values from
four independent experiments normalized to those of untreated neurons are
plotted. Cycloheximide affected the size (a, b and c, P#0.001; d, not
significant) and the number of the synaptic XRN1 puncta (a, b, c and d,
P#0.001), whereas puromycin affected the number (e, P#0.01; f, P#0.001;
g and h, not significant) and elicited almost no effect on the size (e, f and g,
not significant; h, P#0.05, two-way ANOVA, Bonferroni post-test; n510
neurons for each independent experiment). C, control; a.u. arbitrary units.
(B) Live neurons were permeabilized with Triton X-100 (T) or permeabilized
and then treated with RNase A (R) as indicated in Materials and Methods,
and then fixed and stained for the indicated molecules. Representative
dendritic fragments are shown. The presence of dendritic XRN1 bodies was
evaluated in ten neurons from duplicate coverslips with a total of ,1400 mm
dendrite length for each condition. The integrated area of the XRN1 puncta is
plotted relative to control values. Scale bars: 1 mm. Error bars show s.e.m.;
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The presence of synaptic XRN1 bodies inversely correlates
with the protein synthesis rate, and NMDA reduces
translation and enhances their formation
Next, we wondered whether the synaptic XRN1 bodies respond to
synaptic stimulation in a manner that correlates with translational
changes. In particular, we predicted that the decrease in mRNA
translation upon NMDAR stimulation would be accompanied
by an increased assembly of XRN1 bodies and/or some other
mRNA-silencing foci. First, we monitored the local changes in
the protein synthesis rate upon a short stimulation with 30 mM
NMDA or 100 mM DHPG, which stimulates metabotropic
receptors. We treated cultured hippocampal neurons with
agonists as reported previously (Antar et al., 2004; Cougot
et al., 2008; Park et al., 2008; Zeitelhofer et al., 2008; Baez et al.,
2011; Tatavarty et al., 2012; Graber et al., 2013). We treated the
neurons with tetrodotoxin (TTX), a drug that blocks voltage-
gated sodium channels and spontaneous activity, and then we
exposed the cells to a 5-minute pulse of 30 mM NMDA or
100 mM DHPG (see Materials and Methods). For in situ
metabolic labeling of proteins, we used a recently described
strategy termed fluorescent non-canonical amino acid tagging
(FUNCAT) that has been used to monitor dendritic translation
upon exposure to brain-derived neurotrophic factor (BDNF)
(Dieterich et al., 2010) and, more recently, to show the
reactivation of stalled polysomes upon treatment with DHPG
(Graber et al., 2013). We labeled the proteins synthesized before
the stimuli with L-azidohomoalanine (AHA) and the proteins
synthesized during the 15 or 30 minutes after the stimulus with L-
homopropargylglycine (HPG) (Fig. 4A). As expected, NMDAR
stimulation provoked a reduction in the incorporation of HPG,
indicating a reduced local translation rate (Fig. 4A,B; Baez et al.,
2011). By contrast, a DHPG pulse increased the incorporation of
HPG by a factor of two. These observations indicate that NMDA
reduced and DHPG stimulated protein synthesis, which is
compatible with previous reports using different experimental
systems. Among other observations, dendritic translation
evaluated with a transfected GFP-based reporter is stimulated
by DHPG or by NMDAR blockers, and incorporation of amino
acids is reduced in neurons exposed to short pulses of NMDA
(Marin et al., 1997; Job and Eberwine, 2001; Sutton et al., 2004).
Next, we investigated whether the XRN1 puncta respond to
NMDA or DHPG with changes in their number and/or size. As
above, we treated the neurons with TTX before a short
stimulation with NMDA or DHPG, and then transferred them
to conditioned medium. Paralleling the differential effect on the
protein synthesis rate, we found that the NMDA or DHPG pulses
provoked opposite responses. Half an hour after stimulation,
NMDA induced the appearance of new synaptic XRN1 puncta
and their enlargement, whereas a DHPG pulse provoked their
disappearance (Fig. 5A). In both cases, the size and number
was significantly affected and, in subsequent experiments, we
determined the total area of the XRN1-positive puncta at the
synapses, relative to non-treated neurons, as indicated in
Materials and Methods. We followed the response from
immediately after the pulse up to 6 hours afterwards (Fig. 5B–
F). The induction of synaptic XRN1 puncta triggered by NMDA
was maximal at 30 minutes after the pulse and lasted for several
hours. This timecourse roughly correlates with that of the protein
synthesis inhibition triggered by NMDA (Fig. 4A). Conversely,
the stimulation with DHPG provoked both an increase in protein
synthesis and the disappearance of the synaptic XRN1 puncta with
comparable timecourses (Fig. 4A; Fig. 5C–F). These observations
suggest that the assembly of the SX-bodies is linked to the
repression of translation and their disassembly is linked to its
activation. For comparison, we simultaneously analyzed the
response of the S-foci and FMRP granules, which are linked to
synaptic translation. The S-foci are synaptic mRNA-silencing foci
that dissolve upon NMDAR stimulation, thus releasing transcripts
and allowing their translation, and the FMRP-positive granules
disassemble upon mGluR stimulation (Antar et al., 2004; Baez
et al., 2011; Pascual et al., 2012; Graber et al., 2013). We found that
the SX-bodies, the S-foci and the FMRP granules responded to
synaptic stimulation with different patterns. Whereas the SX-
bodies were induced upon NMDAR activation, showing significant
changes at 30 minutes after stimulation, the S-foci immediately
dissolved and the presence of FMRP-positive granules was almost
unaffected by NMDA (Fig. 5B,D–F), as described previously
(Antar et al., 2004; Baez et al., 2011). By contrast, the three types
of foci disassembled upon DHPG stimulation, although with
different kinetics. Whereas the dissolution of the S-foci and FMRP-
positive granules was maximal immediately upon the DHPG pulse,
Fig. 4. NMDA and DHPG differentially affect the protein synthesis rate
at dendrites. Sequential metabolic labeling of proteins with the substituted
amino acids AHA and HPG was performed as indicated in Materials and
Methods to evaluate dendritic protein synthesis before and after the stimulus.
(A) The signal intensities were measured by confocal microscopy at the
indicated times after stimulation and the ratio of HPG:AHA was calculated.
Values normalized to the 15-minute time point of non-stimulated neurons
(basal) are plotted. Mean values from three independent experiments are
plotted, where 150 dendrite fragments from 20 neurons were evaluated in
duplicate (total length, 1200 mm) for each time point and treatment. Error
bars show s.e.m. Statistical significance for each treatment relative to non-
stimulated neurons at each time point is indicated; *P,0.05; ***P,0.001
(two-way ANOVA, Bonferroni post-test). (B) Representative dendrite
fragments depicting the incorporation of AHA (green) and HPG (red) at the
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the synaptic XRN1 bodies started to respond 15 minutes after
stimulation with a maximal effect 30 minutes afterwards (Fig. 5C–
F). At 6 hours after the DHPG pulse, both the SX-bodies and the S-
foci recovered partially (Fig. 5C,D). We also analyzed the effect of
NMDA and DHPG on the dendritic XRN1 and Smaug1 bodies
located outside the synapses, which we termed extra-synaptic
XRN1 and extra-synaptic Smaug1 bodies, respectively. We found
that, as in the case of the bodies associated with synapses, NMDAR
stimulation increased the number of extra-synaptic XRN1 bodies
and reduced the number of extra-synaptic Smaug1 bodies
Fig. 5. SX-bodies, S-foci and FMRP granules
respond differently to NMDA and DHPG
stimulation. (A) The size and number of the
synaptic XRN1 puncta were analyzed in untreated
neurons (None), in neurons exposed to TTX for
16 hours and transferred to normal medium for
35 minutes (TTX), and in neurons exposed to TTX
for 16 hours, pulsed for 5 minutes with NMDA or
DHPG and transferred to normal medium for
30 minutes. Values normalized to those of TTX-
treated cells without TTX withdrawal are depicted.
NMDA and DHPG had opposite effects. Two
hundred synapses from ten neurons from duplicate
coverslips from three independent experiments
were analyzed. Statistical significance for SX-body
size and number relative to non-stimulated neurons
was calculated by two-way ANOVA with Bonferroni
post-test (n510 neurons for each independent
experiment) and was, respectively: a, P#0.01 and
P#0.001; b, P#0.01 and P#0.001; c, P#0.001 and
P#0.001; d, not significant for both size and
number; e, P#0.001 and P#0.001; f, P#0.001 and
P#0.001; g, not significant and P#0.001. a.u.
arbitrary units. (B–F) Neurons were treated with
TTX for 16 hours, exposed to NMDA or DHPG for
5 minutes and transferred to conditioned medium
as above. The integrated area of the synaptic
XRN1-positive bodies, of the S-foci stained with
a specific antibody against Smaug1 and of FMRP-
positive granules present at the synapses was
analyzed and plotted normalized to that of TTX-
treated neurons. For each protein, for each time
point and treatment, a total of 500 synapses from
ten neurons from duplicate coverslips were
analyzed. A representative experiment out of three
is depicted. Error bars show s.e.m. Scale bars:
1 mm.
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(Fig. 6A). The effect of NMDA in extra-synaptic bodies was
significant, but lower than the effect on the bodies close to
synapses. In addition, DHPG had no effect on the extra-synaptic
XRN1 bodies and moderately affected the extra-synaptic Smaug1
bodies (Fig. 6A), suggesting a local effect.
The exposure to NMDA increased the number and size of the
XRN1 puncta and this increases the chances of random
colocalization with synapses. We evaluated the contribution of
the random colocalization between XRN1 and synapsin after
NMDA stimulation as above. We found that, as in resting
neurons, the expected random colocalization was significantly
lower (P#0.0001) than the experimental values (Fig. 6B).
Collectively, all these observations indicate that the dynamics
of the RNA granules containing XRN1, Smaug1 or FMRP are
tightly controlled upon synapse stimulation.
Stress granules form during the translational silencing triggered
by cellular stress, and XRN1 is recruited to stress granules under
specific conditions (Thomas et al., 2009; Thomas et al., 2011). To
investigate whether the XRN1 puncta induced concomitantly
with the translational silencing triggered by NMDA are stress
granules, we assessed the presence of the eukaryotic translation
factor 3g (eIF3g, also known as EIF3B), a widely accepted stress
granule marker. Stress granules were not detected at the synapses
upon NMDAR stimulation and neither basal nor induced XRN1-
positive puncta stained positive for eIF3g (Fig. 6C). For
comparison, we treated the neurons with arsenite, a known
inductor of oxidative stress. As expected, stress granules were
Fig. 6. NMDA and DHPG trigger mostly a local effect and the mTOR pathway regulates SX-body assembly upon NMDAR stimulation. (A) Cultured
hippocampal neurons were exposed to NMDA or DHPG as described for Fig. 5 and stained for synapsin and XRN1 or for synapsin and Smaug1. The integrated area
of the puncta associated with synapses (Syn) or not in contact with synapses (Extrasyn) was analyzed at the indicated time points. Values normalized to those
of the TTX-treated neurons are plotted. a.u., arbitrary units. Error bars show s.e.m. *P#0.05; **P#0.001; ***P#0.0001; ns, not significant (statistical significance
relative to untreated neurons as determined by using one-way ANOVA with Bonferroni post-test). (B) Random colocalization for XRN1 and synapsin was analyzed in
five representative dendritic fragments immediately after the NMDA pulse or 30 minutes after the pulse, as in Fig. 1. In all cases, P#0.0001 in all pairs experimental
versus random. Error bars show s.d. (C) Neurons were pulsed with NMDA for 5 minutes and transferred to conditioned medium for 60 minutes, or treated with
arsenite (Ars) for 60 minutes, and the indicated molecules were immunostained. Ten randomly selected neurons were analyzed and the stress granule marker
eIF3g was never detected in the XRN1 dendritic puncta. Cont, control. (D,E) Neurons were exposed to NMDA in the presence or absence of the PI3K inhibitor
LY294002 (LY) or the mTOR inhibitor rapamycin (Rap). The size and number of XRN1-positive puncta at the synapse was evaluated 30 minutes after the pulse, as
above. A total of 200 synapses from ten neurons randomly selected from duplicate coverslips were analyzed for each treatment. Error bars show s.e.m. Statistical
significance relative to untreated neurons as determined by using one-way ANOVA with Bonferroni post-test (n510 neurons for each independent experiment)
was as follows: size and number upon NMDA treatment, P,0.0001 and P,0.05, respectively; all other cases, not significant. Scale bars: 1 mm.
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detected in the cell soma and dendrites upon the oxidative stress
stimulus, and we found that they did not contain XRN1 (Fig. 6C,
lower panel). Thus, the XRN1-positive bodies present in resting,
NMDA-stimulated or stressed neurons were not stress granules.
Finally, we investigated whether the mTOR pathway is
involved in SX-body dynamics. mTOR is activated upon
NMDAR stimulation and mediates the repression of a number
of messengers and the translational activation of others (Sosanya
et al., 2013). We found that the pharmacological inhibition of
mTOR or of the upstream kinase phosphoinositide 3-kinase
(PI3K) with specific drugs blocked the formation of synaptic
XRN1 puncta triggered by NMDA (Fig. 6D,E). Thus, local
translation and SX-body dynamics are both under the control of
the mTOR pathway, suggesting that they are coordinately
regulated or linked in a cause–consequence relationship.
XRN1 contributes to the translational silencing upon
NMDAR stimulation
The above experiments indicate that the SX-bodies behave as
mRNA-silencing foci that form and grow in size when local protein
synthesis is repressed. We speculated that the XRN1-positive
bodies help the translational silencing elicited by NMDA, and we
analyzed the effect of XRN1 knockdown with a specific siRNA
pool (siXRN1). If the XRN1-positive bodies directly regulate
translation, then XRN1 knockdown should attenuate the decrease
in translation induced by NMDA.
First, we evaluated the efficiency of the XRN1 knockdown in
cultured neurons. Western blot analysis indicated a significant
reduction in XRN1 levels (Fig. 7A). In addition, the number of
XRN1-positive puncta in synapses and in the dendritic shaft was
reduced to half of the basal number (Fig. 7A). Then, we exposed
the neurons to an NMDA pulse and analyzed the protein synthesis
rate in situ, before and after the stimulus (see Fig. 4 above). As
expected, NMDAR stimulation provoked a global reduction in
the translation rate in the neurons treated with a control siRNA.
At 30 minutes after the pulse, the incorporation of HPG was
reduced to 0.53 (60.06; P50.0036; 6s.e.m.) relative to non-
stimulated neurons. By contrast, XRN1-knockdown neurons
showed a considerably weaker response and protein synthesis
was not significantly reduced, as we found that the incorporation
of HPG was 0.83 (61.4; not significant) relative to control
neurons (Fig. 7B,C). These results suggest that XRN1-positive
bodies contribute to the local translational silencing elicited by
NMDA, likely by masking or degrading transcripts.
DISCUSSION
Regulation of translation by synaptic activity is key to plasticity
and homeostasis. NMDAR stimulation globally inhibits dendritic
protein synthesis with consequences for translation specificity
(reviewed in Thomas et al., 2014). Here, we show that the
translational silencing upon exposure to NMDA is linked to the
formation of synaptic XRN1-positive bodies, which are novel
post-synaptic bodies that contain XRN1 and apparently lack
decapping activity and that we termed SX-bodies. The SX-bodies
are dynamic; their presence is affected by synaptic stimulation
and inversely correlates with the local translational activity.
Moreover, the disruption of the SX-bodies by XRN1 knockdown
impaired the global translational repression triggered by NMDAR
stimulation, suggesting that the SX-bodies contribute to mRNA
silencing. These results open a number of questions.
What is the nature of the SX-bodies?
We believe that these assemblages store or degrade mRNAs that
are not being translated. Their disparate response to polysome
stabilization or destabilization by specific drugs is comparable to
that of processing bodies and stress granules, and we speculate
that, similarly to processing bodies and stress granules, the SX-
bodies contain repressed transcripts that might return to
Fig. 7. The SX-bodies contribute to the repression of translation upon
NMDAR activation. Neurons were treated with the indicated siRNAs as
indicated in Materials and Methods. (A) XRN1 knockdown was confirmed by
western blotting (left) and by immunofluorescence (right and bottom). The
presence of XRN1-positive puncta was evaluated as above. a.u., arbitrary
units. (B) siRNA-treated neurons were stimulated with NMDA and protein
synthesis was visualized in situ as in Fig. 4. (C) The HPG:AHA ratio after a
30-minute stimulation was evaluated in representative dendritic fragments
from 12 neurons from duplicate coverslips (total length, 700 mm). Mean
values relative to those of non-stimulated neurons averaged from three
independent experiments are plotted. Scale bars: 20 mm (A, upper panel);
1 mm (A, lower panel, B). Error bars show s.e.m. ***P,0.001; ns, not
significant (one-way ANOVA with Bonferroni post test).
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translation. These observations and the sensitivity to RNase argue
strongly against the possibility that the SX-bodies are mere XRN1
storage sites. We unsuccessfully attempted to detect RNA
molecules in the SX-bodies by in situ hybridization strategies,
and this is likely because mRNA masking in granules impairs
detection (Buxbaum et al., 2014). Recent work indicates that
RNA granules might contain stalled polysomes (Graber et al.,
2013). This does not seem to be the case with the SX-bodies, as
they exclude the initiation factor eIF3g and rapidly dissolve upon
polysome stabilization by cycloheximide, which does not affect
stalled polysomes (Graber et al., 2013). For the same reasons, we
speculate that active translation is not possible in the SX-bodies,
even though translation occurs in a number of ribonucleoparticle
(RNP) granules (Tatavarty et al., 2012; Yasuda et al., 2013;
Pimentel and Boccaccio, 2014).
Multiple studies support the notion that the formation of
processing bodies and stress granules is the consequence and not
the cause of the translational silencing (Eulalio et al., 2007;
Buchan and Parker, 2009; Loschi et al., 2009; Thomas et al.,
2011). However, RNA granule formation helps mRNA masking
in dendrites, and the dissolution of related mRNA-silencing foci
containing Smaug1 or Pumilio precedes translational activation in
neurons and oocytes (Baez et al., 2011; Kotani et al., 2013;
Buxbaum et al., 2014; Park et al., 2014). We propose that the SX-
bodies mask mRNAs and that the regulation of SX-body
dynamics directly affects their translation.
What are the molecular mechanisms for mRNA silencing in
the SX-bodies?
The SX-bodies appear to exclude decapping activity, as they
do not contain DCP1a, an obligate co-factor that activates
the enzymatic subunit DCP2. Similarly, independent bodies
containing Pacman or DCP1a are present in the Drosophila
oocyte (Lin et al., 2008). Indirect evidence additionally indicates
that the SX-bodies also lack the decapping co-activators Ge-1/
Hedls/RCD8/EDC4 and Rck/p54/DDX6. All this suggests that
the SX-bodies are unlikely to represent sites for the processing of
decapped mRNAs, although additional decapping enzymes exist
in several organisms that might bind and activate XRN1 (Li et al.,
2011; Sinturel et al., 2012; Bosse´ et al., 2013). Similarly, only a
small fraction of dendritic DCP1a foci contain XRN1 (this work
and Cougot et al., 2008), indicating that 59-39 degradation is
unlikely to occur in the DCP1a foci. Moreover, we speculate that
decapping is not a major activity at the DCP1a foci, given that the
molecular interaction of the decapping machinery with XRN1 is
important for efficient decapping (Braun et al., 2012; Jonas and
Izaurralde, 2013). We and others have found that NMDA or
kainic acid induce the dissolution of dendritic DCP1a foci,
whereas these stimuli enhance the formation of XRN1 bodies
(this work; L.L. and G.L.B., unpublished; Cougot et al., 2008;
Zeitelhofer et al., 2008). The disparate responses of dendritic foci
containing XRN1 or DCP1a upon synaptic stimulation further
indicate that decapping and 59-39 decay are not coordinated in
these bodies, and all this strongly suggests that both types of
bodies are dendritic mRNA storage compartments.
Besides decapping, the endonucleolytic cleavage linked to NMD
or to RISC-mediated silencing generates 59 monophosphorylated
ends that might serve as XRN1 substrates (Lejeune et al., 2003;
Gatfield and Izaurralde, 2004; Souret et al., 2004; Bagga et al.,
2005; Eberle et al., 2009; Huntzinger and Izaurralde, 2011;
Nagarajan et al., 2013). Both pathways involve processing bodies,
are active at dendrites and are regulated by synaptic stimulation,
opening the possibility that the SX-bodies are relevant to these
mechanisms (Giorgi et al., 2007; Schratt, 2009; Hillebrand et al.,
2010; Huang et al., 2012). Arc/Arg3.1 mRNA, an important
transcript activated at several levels upon synaptic stimulation is
targeted to a NMD-related pathway termed translation-dependent
decay (TDD) that might affect additional transcripts (Giorgi et al.,
2007). Relevantly, recent work demonstrated that NMDAR
stimulation induces the degradation of Arc/Arg3.1 mRNA at
activated synapses, opening the possibility of a role for XRN1
(Farris et al., 2014). Staufen-mediated decay (SMD) is an additional
pathway for regulated mRNA degradation, and RNA granules
containing Staufen1 and Staufen2 are abundant in dendrites
(Zeitelhofer et al., 2008; Park and Maquat, 2013). Relevantly, the
NMD, TDD and SMD pathways involve Upf proteins, which
directly interact with XRN1 (Nagarajan et al., 2013). Whether
dendritic mRNAs cleaved by NMD, TDD, SMD or RISC are
further processed in the SX-bodies remains to be investigated.
Among other possible targets, degradation of mRNAs coding for
translational activators might provide a link between XRN1 and the
control of protein synthesis upon NMDAR stimulation.
However, our results are more compatible with a role for the
SX-bodies in mRNA storage. In this model, XRN1 catalytic
activity would not be involved and mRNAs resistant to 59-39
decay would be released in a regulated manner from the SX-
bodies (Fig. 8A). XRN1 is a large molecule and the catalytic
domain and additional protein regions required for degradative
activity span only two thirds of its length, opening the possibility
of additional molecular functions (Chang et al., 2011; Braun
et al., 2012; Nagarajan et al., 2013). Remarkably, XRN1 displays
several short regions enriched in lysine and/or glutamic acid
(Fig. 8B), speculatively linked to RNA binding (Castello et al.,
2012; Kramer et al., 2014). It is also relevant that proteins from
the XRN1 family affect selected mRNAs, and transcripts carrying
G-quartets – which are important motifs in dendritic mRNAs –
are preferentially bound by mammalian XRN1 (Bashkirov et al.,
1997; Darnell et al., 2001), all these putatively providing
mechanisms for selective storage.
We propose that the XRN1-dependent pathway for mRNA
silencing is enhanced upon NMDAR activation and weakened upon
DHPG stimulation (Fig. 8A). NMDAR activation bidirectionally
affects dendritic translation through multiple pathways. NMDAR
stimulation provokes the translational repression of the voltage-
gated potassium channel Kv1.1 by miR-129 and the mTOR
pathway, which we found mediates SX-body formation (Raab-
Graham et al., 2006; Sosanya et al., 2013). In addition, NMDA
impairs elongation through the phosphorylation of the eukaryotic
elongation factor 2, with a differential effect on specific transcripts
and a global decrease in the protein synthesis rate (Marin et al.,
1997; Sutton et al., 2006; Sutton et al., 2007). Whether miRNA-
mediated repression or elongation inhibition are linked to SX-body
formation is currently unknown. Likewise, whether mRNA
silencing in the SX-bodies affects the translational activation of
NMDAR-dependent transcripts remains to be explored.
How are the SX-bodies regulated?
Our observations underscore a novel repression pathway that
involves the interaction of messenger molecules with XRN1 in
specific cellular microdomains. The assembly of RNA granules,
processing bodies and stress granules, as well as their
dissolution, are currently conceptualized as phase-transition
processes (Brangwynne, 2013; Hubstenberger et al., 2013;
Jonas and Izaurralde, 2013; Toretsky and Wright, 2014), and
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we believe that the dynamics of the SX-bodies are under similar
rules. According to this model, all these bodies behave as liquid
droplets of ribonucleoparticles (RNPs) that dynamically exchange
molecules with the cytosol. Phase transitions of RNP liquid
droplets are controlled by changes in the local concentrations of
their components, and we found that the availability of non-
polysomal mRNA affects the size and the number of the SX-
bodies. RNA molecules might contribute to the stability of RNP
liquid droplets by serving as a platform for multiple binding, and
we found that RNA breakdown affects SX-body integrity.
Additional cohesive forces that might help the condensation of
RNP liquid droplets depend on homotypic and heterotypic
protein–protein interaction mediated largely by low complexity
regions (LCRs) (Han et al., 2012; Kato et al., 2012; Brangwynne,
2013; Jonas and Izaurralde, 2013; Thomas et al., 2014). The
XRN1 C-terminus displays several LCRs, some of them rich in
proline, and we speculate that these LCRs are likely to play a role
in SX-body aggregation (Fig. 8B). How the mTOR pathway
affects SX-body aggregation and whether post-translational
modifications influence XRN1 stabilization or degradation
remains to be investigated. In addition, whether other proteins
present in the SX-bodies contribute to their formation is currently
unknown. So far, we found that several important RBPs that form
granules – namely FMRP, Smaug1 and SMN – are excluded from
the SX-bodies. Finally, condensation of liquid droplets is
influenced by several physicochemical parameters, as well as
by constraints imposed by the cytoskeleton network and
molecular crowding (Brangwynne, 2013). Modulation of these
factors by neuronal activity provides additional mechanisms for
the regulated formation of SX-bodies and other RNP
assemblages.
In addition to SX-body aggregation, translational regulation
upon exposure to NMDA is accompanied by the dissolution of the
S-foci and DCP1a foci, with the apparent release of CaMKII
mRNA and other messengers yet to be identified (Cougot et al.,
2008; Zeitelhofer et al., 2008; Baez et al., 2011). These responses
are specific to NMDAR stimulation, and mGluR activation
generates a different pattern. The SX-bodies, the S-foci and the
FMRP granules dissolve upon mGluR stimulation with different
timecourses, likely to allow the ordered translation of specific
messengers. We propose that the concerted assembly and
disassembly of different RNP liquid droplets increases
translational diversity in response to different synaptic inputs
(Fig. 8A).
MATERIALS AND METHODS
Neuron culture, siRNA treatment and plasmid transfection
All experiments involving animals were conducted according to the
protocols approved by the Institutional Animal Care and Use Committee
(IACUC) of the Fundacio´n Instituto Leloir. Hippocampal cultures were
prepared as described previously (Baez et al., 2011). Briefly, hippocampi
were dissected from Sprague Dawley rats at embryonic day 18 and
digested with trypsin. Cells were seeded on poly-D-lysine-coated glass
coverslips (Sigma-Aldrich) and maintained at 5% CO2 in Neurobasal
medium (NB) supplemented with B27 and glutamine (complete NB), all
reagents and nutrients from Invitrogen. All experiments were performed
at 17 days in vitro unless otherwise indicated. For siRNA treatment,
neurons were allowed to grow for 6 days in vitro, incubated with 100 nM
siRNA complexed with Lipofectamine 2000 Transfection Reagent
(Invitrogen) for 4 hours, and analyzed at 10 days afterwards unless
otherwise indicated. A pool of four double-stranded (ds)RNAs (59-CUA-
AAGAAACUGCGGCUAU-39, 59-GAACAUACUACAUGACGAA-39,
59-CCAAAGAGGCGUAGACUCA-39 and 59-GCUCACAGGUCGUA-
GAUAU-39) against rat XRN1 (L-080615-01-0010) or a non-targeting
pool of siRNAs (siNT) (D-001810-10); both from Dharmacon, Chicago,
IL, were used. Plasmid transfection was performed 3 days after plating
using Lipofectamine 2000 Transfection Reagent.
Cycloheximide and puromycin (Sigma-Aldrich) were used at 250 mg/
ml and neurons were exposed for 10 minutes. Treatment with 100 mg/ml
RNase A (Sigma) in conditioned complete NB was performed for
Fig. 8. Summary and model for SX-body dynamics.
(A) Our observations indicate that NMDAR stimulation
downregulates protein synthesis and induces the formation
of the SX-bodies, which help translational silencing.
Simultaneously, the S-foci dissolve, releasing transcripts to
allow their translation. FMRP granules are not affected upon
NMDA, but rapidly dissolve or remodel upon mGluR
stimulation, likely releasing polysome stalling or other
mechanisms for translation repression. The SX-bodies
respond in a second wave and slowly dissolve upon mGluR
activation, speculatively allowing the translation of masked
transcripts. The S-foci are affected by DHPG in a similar
manner. Multiple mRNA species are silenced upon NMDAR
activation, and the identity of the transcripts masked in the
SX-bodies remains unknown. See Discussion for details.
(B) Structure of mammalian XRN1. The catalytic domain
(orange boxes) in human XRN1 (NP_061874) spans amino
acids 1–595, and a conserved region up to amino acid 1174
is additionally required for enzymatic activity (Chang et al.,
2011, reviewed in Nagarajan et al., 2013). A region that
binds the decapping machinery is located at the C-terminal
30 amino acids (not depicted) (Braun et al., 2012). Short
LCRs (yellow boxes) are abundant in the C-terminal part.
Stretches rich in Glu and/or Lys or with high proline content,
putatively involved in RNA binding and protein aggregation,
are indicated. These features are conserved in the rat,
chicken and zebrafish molecules (XP_002730002.1,
XP_422596.3 and NP_957327.2, respectively). Schemes
are drawn to scale and human XRN1 spans 1706 residues.
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5 minutes after a 5-minute permeabilization with 0.1% Triton X-100 in
conditioned complete NB, as described previously (Thomas et al., 2012).
In all cases, stock solutions were diluted into complete NB medium.
Neuron stimulation and metabolic labeling of proteins
Before synaptic stimulation, neurons were exposed for 16 hours to 1 mM
TTX (Tocris Bioscience). Stimulation with 30 mM NMDA (Sigma-
Aldrich) or 100 mM DHPG (Tocris Bioscience) for 5 minutes and
recovery in complete NB were performed as described previously (Baez
et al., 2011). For metabolic labeling of proteins, neurons were treated for
16 hours with TTX in complete NB and incubated for 30 minutes in
methionine-free DMEM (Sigma-Aldrich) plus TTX. Then, 1 mM AHA
was added for 15 minutes. After a 5-minute pulse with NMDA, cells
were incubated with 1 mM HPG for the indicated times in methionine-
free DMEM (Sigma-Aldrich). After fixation and permeabilization, cells
were incubated with Alexa-Fluor-488–alkyne [Alexa Fluor 488 5-
carboxamido-(propargyl), bis (triethylammonium salt)], which reacts
with the AHA azide group, and then with Alexa-Fluor-594–azide [Alexa
Fluor 594 carboxamido-(6-azidohexanyl) bis(triethylammonium salt)],
which reacts with the alkyne group of HPG-bearing proteins. All reagents
were from Invitrogen. Signal intensity was measured by confocal
microscopy in dendrite fragments located at 50 mm or more from the
soma to minimize the contribution from proteins delivered from the cell
body (Dieterich et al., 2010).
Immunofluorescence
Immunofluorescence of cultured cells was performed after fixation,
permeabilization and blocking as usual (Baez et al., 2011; Thomas et al.,
2012). Primary antibodies were diluted as follows: rabbit anti-mammalian
XRN1 used in Fig. 1A,D; Fig. 2A–C; Fig. 3A,B; Fig. 5A–F; Fig. 6 and
Fig. 7A (Bethyl Laboratories), 1:100; rabbit anti-mammalian XRN1
provided by Jens Lykke-Andersen (Division of Biological Sciences,
University of California, San Diego, USA), 1:100; anti-Smaug1/Samd4a
prepared in our laboratory, 1:500 (Baez and Boccaccio, 2005); monoclonal
IgG2a anti-DCP1a (Abnova Corporation), 1:1000; polyclonal rabbit anti-
Ge-1/Hedls/RCD8/EDC4 or anti Rck/p54 (Bethyl Laboratories, Inc.), 1:500;
IgG2b anti-tubulin bIII (Sigma-Aldrich), 1:500; IgG1 anti-synapsin I
(Synaptic Systems), 1:100; IgG2b anti-FMRP, clone 7G1-1 (Developmental
Studies Hybridoma Bank), 1:50; and goat anti-eIF3g N-20 (Santa Cruz),
1:250; anti-V5 (Invitrogen), 1:500. Secondary antibodies coupled to Alexa
Fluor 488, Alexa Fluor 555 or Alexa Fluor 666 (Invitrogen) were used at
1:500–1:1000. Secondary antibodies coupled to Cy2, Cy3 or Cy5 (Jackson
ImmunoResearch Laboratories, Inc.) were used at 1:300–1:500.
Brain sections, provided by Alejandro Schinder (Fundacio´n Instituto
Leloir, Argentina) and Alberto J. Ramos (University of Buenos Aires,
Argentina) were stained following a free-floating method, as described
previously. Briefly, after antigen retrieval by treatment at 95 C˚ for
5 minutes, sections were blocked in 10% normal donkey serum in PBS
containing 0.3% Triton X-100, and incubated overnight with anti-XRN1
(1:100), anti-synapsin (1:200) and anti-tubulin bIII (1:200) at 4 C˚. The
secondary antibodies donkey anti-rabbit-IgG and anti-mouse-IgG1 or
-IgG2b (Jackson ImmunoResearch Laboratories, Inc.) were used at
1:250. Sections were mounted in PVA-Dabco (Sigma-Aldrich).
Image analysis
Images were acquired with a PASCAL-LSM or a LSM510 Meta confocal
microscopes (Carl Zeiss), using C-Apochromat 406/1.2 W Corr or 636/
1.2 W Corr water-immersion objectives for the LSM, and an EC Plan-
Neofluor 406/1.30 NA oil or Plan-Apochromat 636/1.4 NA oil
objectives for the LSM510 Meta. Images were acquired with LSM
software (Carl Zeiss), and pixel intensity was always lower that 250
(saturation level is 255). Equipment adjustment was assessed by using 1-
mm FocalCheck fluorescent microspheres (Invitrogen). Images were
randomly selected for sampling, using the MAP2 or synapsin
immunostaining or the AHA signal to select the dendritic fragments to
be analyzed. No filters or gamma adjustments were used prior to the
analysis of the size, number or intensity of the objects, which was
performed with the ImageJ software. A synapse was considered to be
positive when a focus overlapped at least 25% with the synapsin I patch.
The area of the foci associated with synapses was measured with ImageJ
and a value of zero was assigned to negative synapses.
Random colocalization of granules and synapses was evaluated by
using methods described previously (reviewed in Dunn et al., 2011). The
channel corresponding to XRN1, DCP1a or Ge-1/Hedls/RCD8/EDC4
was randomized by block scrambling or displacement along the dendritic
axis. The use of blocks larger than the particles to be analyzed is
recommended, and we split dendritic fragments into segments of 4 mm
length, and reconstructed images randomized along the dendrite axis.
Randomization by displacement of one channel relative to the other is
obtained when the shift is above a minimal distance that depends on the
size of the objects. Here, we restricted the displacement along the
dendritic axes (x-axis), and analyzed the randomized images generated by
4, 8 or 10-mm displacements. In all cases, the randomized images were
visually inspected to check that the granules did not localize in the
extracellular space, and when possible, images were adjusted with
minimal displacements along the y-axis or a 180˚ rotation to fit all pixels
inside the dendrite area. Single and double-labeled pixels were analyzed
by ImageJ.
Hippocampus fractionation
Hand-dissected hippocampi from adult mice were fractionated as
described previously (Baez et al., 2011). Briefly, a crude synaptosome
preparation was extracted in 2% Triton X-100 pH 6, followed by 1%
Triton X-100 pH 8.0, to obtain a fraction enriched in soluble presynaptic
components and a fraction containing postsynaptic densities and
insoluble presynaptic proteins.
Western blotting
Western blotting was performed by standard procedures using Immobilon-P
polyvinylidene difluoride membranes (Millipore), ECL Prime (GE
Healthcare) and Hyperfilm (GE Healthcare). Primary antibodies were used
as follows: rabbit anti-XRN1, diluted 1:5000; anti-PSD95 (Upstate
Technologies), 1:1000; anti-synapsin I (Synaptic Systems), 1:5000.
Secondary antibodies conjugated to peroxidase (Sigma) were used at 1:5000.
Statistics
Each experimental point includes duplicates or triplicates, as indicated.
P-values relative to control treatments according to two-way ANOVA or
the indicated test were determined using Instat software (GraphPad
Software, Inc.). The number of synapses, neurons and dendritic lengths
analyzed are indicated for each case.
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